2/12
04:35 pm
aim
CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering
Low
Report
CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering
2/12
09:16 am
aim
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event [Yahoo! Finance]
Low
Report
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event [Yahoo! Finance]
2/12
08:55 am
aim
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event
Medium
Report
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event
2/11
08:30 am
aim
AIM ImmunoTech Announces Commencement of Rights Offering
Medium
Report
AIM ImmunoTech Announces Commencement of Rights Offering
2/6
09:09 am
aim
AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial [Yahoo! Finance]
Neutral
Report
AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial [Yahoo! Finance]
2/6
08:55 am
aim
AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Neutral
Report
AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
2/5
08:40 am
aim
AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
Medium
Report
AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
1/27
04:35 pm
aim
AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering
Low
Report
AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering
1/23
01:22 pm
aim
AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering
Low
Report
AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering
12/30
06:43 pm
aim
AIM ImmunoTech Announces Stock Dividend [Yahoo! Finance]
High
Report
AIM ImmunoTech Announces Stock Dividend [Yahoo! Finance]
12/30
05:10 pm
aim
AIM ImmunoTech Announces Stock Dividend
High
Report
AIM ImmunoTech Announces Stock Dividend
12/16
01:29 pm
aim
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B [Globe and Mail, The (Toronto, Canada)]
Low
Report
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B [Globe and Mail, The (Toronto, Canada)]
12/10
09:00 am
aim
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
Low
Report
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
12/1
09:13 am
aim
AIM ImmunoTech to Participate in Live ‘Fireside' Chat on Virtual Investor Closing Bell Series [Yahoo! Finance]
Medium
Report
AIM ImmunoTech to Participate in Live ‘Fireside' Chat on Virtual Investor Closing Bell Series [Yahoo! Finance]
12/1
08:55 am
aim
AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series
Low
Report
AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series
11/18
04:12 pm
aim
AIM ImmunoTech GAAP EPS of -$1.57 misses by $0.59 [Seeking Alpha]
Neutral
Report
AIM ImmunoTech GAAP EPS of -$1.57 misses by $0.59 [Seeking Alpha]
11/18
08:55 am
aim
AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program
Medium
Report
AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program